Rehard Robert, EVP and CFO of RRX, has demonstrated a clear pattern of net selling in his insider transactions, with $3.38 million in total sales compared to just $26,762 in buys across 24 filings. His activity is concentrated solely in RRX, with no trades in other companies. The bulk of his selling occurred in February 2026, including three disposals worth $215,864 on February 25, $287,614 on February 24, and a larger $1.67 million sale on February 9. These recent sales follow smaller, periodic acquisitions through awards, such as $3,448 in January 2026 and $3,439 in October 2025, which appear to be part of recurring equity compensation.
The transactions suggest a long-term divestment strategy rather than short-term trading. While Robert has received consistent small equity grants (typically under $3,500), his sales have been significantly larger and more concentrated in timing. Notably, his February 2026 disposals were preceded by earlier sales in February 2025 and February 2024, each involving six-figure transactions. The absence of any recent buys—coupled with the acceleration of sales in early 2026—indicates a sustained reduction in his RRX holdings. The filings show no open market purchases, with all acquisitions tied to awards, reinforcing the net outflow of shares.
AI-assisted summary